Similarly, NAT2 phenotypes have been associated with differential cancer risk following exposures to aromatic amine carcinogens metabolized by NAT2 (García-Closas et al., 2005; Agúndez, 2008; Moore et al., 2011; Hein, 2018). The gene discussed is NAT2; the disease is cancer.